NEXUS Biosystems’ Universal Store Compound Management System Selected as Key Component of Vanderbilt University’s High-Throughput Screening Facility
NEXUS Biosystems’ Universal Store Compound Management System Selected as Key Component of Vanderbilt University’s High-Throughput Screening Facility
Last Updated on Friday, 12 January 2007 11:05 Written by admin Friday, 12 January 2007 11:05
POWAY, CALIF., January 11 /CNW/ - NEXUS Biosystems announced that Vanderbilt University's High-Throughput Screening (HTS) Facility has selected the Universal Store to manage its ever-growing collection of synthetic small molecules and natural products. The Universal Store will serve as the main repository for maintaining and managing Vanderbilt's collection as a part of its basic research and translational drug discovery activities. Multiple local and extramural medicinal, synthetic, and natural products-based chemistry efforts contribute to the population of this collection. This collection is utilized in large part by the Vanderbilt Institute of Chemical Biology's (VICB) High-Throughput Screening (HTS) Facility. This facility utilizes state-of-the-art instrumentation and data management tools to interrogate chemical libraries, enabling identification of compounds and reagents for use in basic research, therapeutics, and diagnostics. The facility serves the Vanderbilt research community in developing and running HTS on a wide variety of targets using Vanderbilt's local chemical compound collection. In addition the facility exists as a national resource for screening G-protein coupled receptors (GPCRs), ion channels, and transporters as one of the ten-member, NIH-funded, Molecular Libraries Screening Center Network (MLSCN): http://mli.nih.gov/mlscn/index.php "We are very excited about the selection of our instruments as a major component of the VICB's on-going research initiative," stated Tommy Bui, VP of Business Development for NEXUS. "The VICB requires a sample management system that can achieve demanding requirements for performance, reliability, and most importantly, sample integrity. Vanderbilt's decision to implement the Universal Store further validates NEXUS' technology as a premier solution for the storage, retrieval, and management of diverse chemical libraries." Dave Weaver, Director of the Vanderbilt HTS Facility, said, "We are thrilled to be working with NEXUS to deploy its compound storage and management system. We extensively evaluated numerous compound management systems and we particularly prized the Universal Store's flexibility, scalability, and functionality. For us, getting a system that was able to serve our present needs while being built on a design philosophy that ensures its ability to accommodate future advancements in compound storage was extremely appealing." About NEXUS Biosystems, Inc. NEXUS Biosystems, a privately held company based in Poway, California, USA, has since 1996 been a developer and provider of enabling technologies and automation systems for pharmaceutical, biotech, agrochemical, and academic research institutions worldwide. Current products include the Universal Store(R) family of next-generation sample storage and retrieval systems, the Crystal Farm(R) line of protein crystallization systems, the IRORI(R) line of chemical synthesis technologies and services, and in No. America and Asia NEXUS is a distributor of the Covaris(TM) line of ultrasonic products for sample dissolution, resolubulization, and high density microplate mixing. About the Vanderbilt Institute of Chemical Biology The Vanderbilt Institute of Chemical Biology is a trans-institutional initiative between the College of Arts and Sciences and the School of Medicine. The Institute's mission is to provide research and training in the application of chemical approaches to the solution of important biomedical problems. The proximity of the Chemistry Department and the School of Medicine facilitates this process. Our members represent a range of research interests and technologies with particular strengths in analytical methodology and molecular imaging, cellular responses to chemical stress, drug discovery, enzyme and receptor chemistry, proteomics, structural biology, and chemical synthesis.
For further information: NEXUS Biosystems Tommy Bui, VP, Business Development (858) 679-0770
This entry was posted on Friday, January 12th, 2007 at 11:05 pm and is filed under Equipment & Supplies, HT Screening, North America, Press Releases.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.
Main Menu
- Home
- About Bioscreening.net
- Glossary
- Biotechnology Glossary A-I
- Biotechnology Glossary J-Q
- Biotechnology Glossary R-Z
- Bird Flu
- Cheminformatic Glossary
- Endotoxins
- Fullerenes
- Genipin
- Gossypol (Gossipol)
- Grants, Venture Capital, and Government Funding
- High-throughput screening
- Lipinski Rule-of-Five
- Mumie
- Natural Medicine
- Rule-of-Three (Ro3)
- Targeted Libraries
- Web Directory